Community/Retail

Investigational COVID-19 antibody was authorized in a 700 mg dose for adults and pediatric patients 12 years and older and should be administered as soon as possible after diagnosis and within 10 days of symptom onset.

A new study suggests that COVID-19 antibodies remain in the body for up to 5 months.

Even in a relatively asymptomatic case of COVID-19, it is possible that the virus could have fostered retrograde reactivation of the varicella-zoster virus.

Pfizer and BioNTech plan for submission to the FDA for an Emergency Use Authorization soon after the required safety milestone is achieved in mid-November for a promising novel COVID-19 vaccine candidate.

Sleep deficiency may impair the ability to cognitively filter intrusive memories and thoughts when confronted with reminders of them, according to a recent study.

The processes involving the high prevalence of diagnosis and over prescription undoubtedly play a role, but it is possible that the infra-diagnosis and lower prescription rates in men could be a factor, according to the study authors.

Janssen Pharmaceutical Companies submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of rivaroxaban in patients with peripheral artery disease.

Rite Aid announced the launch of its rebranded identity as part of its RxEvolution strategy, which is designed to transform the company into a leading whole health destination.

Novel COVID-19 vaccine uses nanoparticles instead of targeting the spike protein.

The pharmacist plays a critical role in supporting the care plan developed between the patient and the physician.

Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.

Patients recently diagnosed with cancer are significantly more likely to quit smoking and remain tobacco-free if they receive frequent phone counseling over an extended period of time.

The drug combination of dapagliflozin and exenatide continues to stay effective without a loss of effect after 2 years of continual use in patients with type 2 diabetes (T2D), according to researchers at Thomas Jefferson University.

While most COVID-19 mutations do not affect disease severity, some may have made it more contagious.

By simulating inhalation, exhalation, coughs, and sneezes in the laboratory, the researchers discovered that non-woven fabrics used in most masks work well to demonstrate the concept.

Study shows that 61% of patients who either were not prescribed CPAP to treat their sleep apnea or were not adherent to their CPAP treatment were hospitalized with influenza.

Investigators demonstrated that protection from COVID-19 transmission increases with physical distancing in an approximately linear proportion.

Following tobacco’s introduction to Europe by the Spanish in the 16th century, European physicians embraced it exuberantly, dubbing it a panacea.

There are a number of ways to examine issues around supporting and developing pharmacy technicians, but perhaps the best way is to frame the issue using an organizational behavior lens.

Questions remain whether recovered COVID-19 patients who test positive are still contagious.

Further research is essential in order to determine the relationship between diabetes and COVID-19 and what impact glucose-lowering drugs may have.

Research suggests global access to COVID-19 vaccines is best for both global health and finances.

The greater effect on population-wide alcohol use could be tied to the effects of the COVID-19 pandemic, including widespread social disruption and isolation, limited social support and access to medical care, and negative domestic and global economic impacts.

Inappropriately prescribed medications can increase the risk of serious adverse effects and increase the cost of care.

Pharmacy Times® interviewed Amanda Epp, MBA, the CEO of ScriptDrop, on how granting provider status to pharmacists can allow them to better support the health care system in the fight against COVID-19.

Study suggests psilocybin may be effective in a much wider population of patients suffering from major depression than previously believed.

Study shows large reductions in visits to essential stores during the pandemic, such as pharmacies, but found essentially no reduction in non-essential visits to parks and other outdoor spots.

Researchers from 2 independent studies have found that SARS-CoV-2 may be more capable of infecting human cells due to the virus’ spike protein recognizing and binding to neuropilin-1.